Tethis S.p.A. announces enrollment of the first two patients in a clinical study of its See.d platform which allows automated standardized plasma and cell sample preparation for multiomic liquid biopsy

Posted on by

MILAN, April 2, 2024 /PRNewswire/ — Tethis S.p.A., a pioneer in the development of an innovative platform for liquid biopsy testing, is pleased to announce the enrollment of the first two patients in the clinical study TET-22-001. This study, titled “Feasibility evaluation of See.d…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.